dc.contributor.author
Werner, Franziska
dc.contributor.author
Schumacher, Fabian
dc.contributor.author
Mühle, Christiane
dc.contributor.author
Adler, Werner
dc.contributor.author
Schug, Caterina
dc.contributor.author
Schäflein, Eva
dc.contributor.author
Morawa, Eva
dc.contributor.author
Kleuser, Burkhard
dc.contributor.author
Kornhuber, Johannes
dc.contributor.author
Erim, Yesim
dc.contributor.author
Rhein, Cosima
dc.date.accessioned
2025-11-07T06:01:06Z
dc.date.available
2025-11-07T06:01:06Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47310
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-47028
dc.description.abstract
Objective
Chronic stress is a risk factor for developing stress-induced mental disorders like major depression and post-traumatic stress disorder. Low-grade inflammatory processes seem to mediate this association. The sphingolipid metabolism with its most important lipid messengers ceramide and sphingosine-1-phosphate (S1P) was shown to play an important role in the pathophysiology of affective disorders and inflammation.
Method
We conducted an exploratory trial to investigate the effect of intensive psychosomatic - psychotherapeutic treatment of stress-induced disorders on the biological level. Before and after eight weeks of treatment, blood plasma of 67 patients was analyzed for sphingolipid levels and their metabolizing enzymes. Symptom severity of depression (PHQ-9), anxiety (GAD-7), and somatization (PHQ-15) was assessed in parallel.
Results
During psychosomatic - psychotherapeutic treatment, symptom severity of depression, anxiety, and somatization decreased significantly. Levels of the stress molecule cortisol decreased upon treatment. Enzymatic activities of secreted acid sphingomyelinase (S-ASM) and neutral sphingomyelinase (NSM) increased significantly upon treatment, as well as of neutral ceramidase (NC). Regarding the lipid level, the molar ratio of ceramide species Cer16:0 and Cer18:0 decreased upon treatment, whereas sphingosine and S1P levels increased.
Conclusions
Psychosomatic – psychotherapeutic treatment was associated with a reduction in specific ceramide ratios and an increase in sphingosine and S1P levels potentially resulting from increased activity of sphingolipid metabolizing enzymes. Stress-induced mental disorders might be associated with disturbed sphingolipid levels that seem to be balanced during psychosomatic treatment. This study offers a further piece of evidence that the sphingolipid metabolism could be involved in the pathophysiology of stress-induced disorders, and its analysis could be helpful for treatment monitoring.
en
dc.format.extent
10 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Psychosomatic medicine
en
dc.subject
Sphingosine-1-phosphate, acid Sphingomyelinase
en
dc.subject
Acid ceramidase
en
dc.subject
Stress-induced psychiatric disorders
en
dc.subject
Post-traumatic stress disorder
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::615 Pharmakologie, Therapeutik
dc.title
Psychosomatic - psychotherapeutic treatment of stress-related disorders impacts the sphingolipid metabolism towards increased sphingosine and sphingosine-1-phosphate levels
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00406-025-01985-2
dcterms.bibliographicCitation.journaltitle
European Archives of Psychiatry and Clinical Neuroscience
dcterms.bibliographicCitation.number
7
dcterms.bibliographicCitation.pagestart
2049
dcterms.bibliographicCitation.pageend
2058
dcterms.bibliographicCitation.volume
275
dcterms.bibliographicCitation.url
https://doi.org/10.1007/s00406-025-01985-2
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Pharmazie

refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1433-8491
refubium.resourceType.provider
WoS-Alert